NIH-funded research R21 grant

Investigating how alcohol use disorder medications affect the sense of smell

Official title: Olfactory targets of alcohol use disorder medications

Funded at Oregon Health & Science University · NIH-10946292 · Data updated 2026-11-12

This study is looking at how a hormone called oxytocin might help people with alcohol use disorder by reducing their cravings and drinking, and it’s for anyone who wants to learn about new ways to manage their alcohol consumption.

More Alcohol Use Disorder research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionOregon Health & Science University
NIH-funded
Lab location1 site (Portland, United States)
Project startSeptember 26, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$221,375
NIH project number1R21AA031708-01
Project IDNIH-10946292 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with alcohol use disorder who are seeking new treatment options.

Less likely to help

Patients who do not have alcohol use disorder or those who are not interested in pharmacological treatments may not benefit from this research.

What this research studies

This research explores the effects of oxytocin, a hormone, on alcohol consumption and cravings in individuals with alcohol use disorder. By administering oxytocin intranasally, the study aims to understand how it interacts with the brain's olfactory system to potentially reduce alcohol intake. The researchers will investigate the mechanisms behind oxytocin's effects, particularly focusing on specific brain areas that are involved in the sense of smell and alcohol behavior. This innovative approach seeks to develop more effective treatments for alcohol use disorder.

Why it matters

Potential benefit: If successful, this research could lead to new, more effective treatments for individuals struggling with alcohol use disorder.

How similar studies have gone: Previous studies have shown promising results with oxytocin in reducing alcohol consumption in animal models, but this approach is still being explored in humans.

Where this research is happening

  • Oregon Health & Science University
    Portland, United States
    Active

Researchers

  • Principal investigator: Ryabinin, Andrey E — Oregon Health & Science University
  • Study coordinator: Ryabinin, Andrey E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.